Recursion Pharmaceuticals
RXRX
#5086
Rank
NZ$3.20 B
Marketcap
NZ$5.15
Share price
3.86%
Change (1 day)
-29.99%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2026 (TTM): -NZ$0.84 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are NZ$67.01 Million. In 2025 the company made an earning of -NZ$1.18 Billion a decrease over its 2024 earnings that were of -NZ$0.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.84 Billion-28.36%
2025 -NZ$1.18 Billion38.83%
2024 -NZ$0.85 Billion39.51%
2023 -NZ$0.61 Billion38.68%
2022 -NZ$0.44 Billion30.46%
2021 -NZ$0.34 Billion114.28%
2020 -NZ$0.16 Billion